Wednesday, January 22, 2025

COVID-19: FDA authorizes use of Moderna's

Pamela Cruz. Pen sula 360 Press [P360P].

The Food and Drug Administration (FDA) has issued an emergency use authorization for the second vaccine for the prevention of COVID-19 disease, caused by the SARS-CoV-2 respiratory syndrome.

The emergency use authorization allows the Moderna COVID-19 vaccine to be distributed in the U.S. for use in people 18 and older.